A Bristol Development director jumps to Zeitlin, benefits broker adds two, and more... [From our print edition featured in Monday's City Paper]
Researcher and patient advocate tapped to join three-year international research program aimed at combating breast cancer
Chemotherapy treatment space nearly doubles in size
Former Sarah Cannon COO in charge of adding services